Loss of function mutations in BMPR2, a receptor through which BMP9 and BMP10 modulate endothelial cell signaling [12], are the most commonly associated genetic mutations with the development of PAH [7]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.